Decoding Cleft Lip Risk: Does the MTHFR Gene Play a Role?
"A deep dive into the MTHFR A1298C polymorphism and its potential link to orofacial clefts, separating fact from fiction."
Orofacial clefts (OFCs), including cleft lip and/or palate (CL/P), are common birth defects affecting approximately 90% of craniofacial congenital abnormalities. According to the World Health Organization (WHO), these conditions occur in 0.6 to 1.6 per 1000 newborns worldwide. The prevalence varies based on geographic location, sex, ethnicity, and socioeconomic status, highlighting the complex interplay of genetic and environmental factors.
Research suggests that disruptions in folate metabolism, a critical process for cell growth and development, may contribute to the risk of OFCs. One gene frequently studied in this context is methylenetetrahydrofolate reductase (MTHFR). MTHFR encodes an enzyme crucial for processing folate and maintaining healthy levels of homocysteine, an amino acid. Two common variants (polymorphisms) in the MTHFR gene, C677T and A1298C, have been investigated for their potential roles in OFC development.
While the MTHFR C677T polymorphism has been extensively studied, the A1298C variant has received less attention. Studies examining the association between the MTHFR A1298C polymorphism and OFCs have yielded conflicting results. To clarify this association, a meta-analysis was conducted, pooling data from multiple studies to provide a more comprehensive assessment of the potential link.
Why the Question Matters
Cleft lip, cleft palate, and combined orofacial clefts are important health concerns whose causes are understood to involve multiple influences. The possible contribution of MTHFR variants is tied to broader questions about folate-related biology and genetic susceptibility. Current evidence should therefore be interpreted cautiously rather than as proof that one gene determines an individual's risk.
How Researchers Study MTHFR
Research has commonly examined the maternal and cleft child's MTHFR C677T and A1298C polymorphisms in relation to nonsyndromic cleft lip with or without cleft palate. Studies include population-specific investigations, carefully evaluated existing research, case-control designs, and newer genetic models and statistical approaches. Clinical genetics reviews also emphasize timely, accurate diagnosis and algorithms that can guide testing, although access to genetics providers may vary between institutions.
From Folate to Genetics
Orofacial clefts have long been recognized among the most familiar birth defects, and earlier work reported that folic acid intake during pregnancy could influence their occurrence. Research subsequently broadened toward genetic influences, including studies of MTHFD1 and other genes, alongside investigations of signaling pathways involved in lip and palate formation. More recent reviews place cleft lip and cleft palate within the wider category of orofacial clefts and emphasize their effects on speech, nutrition, and physical well-being.
MTHFR A1298C: Examining the Evidence
A meta-analysis was performed, incorporating data from 11 studies involving 1628 cases of OFCs and 2676 control subjects. Researchers investigated whether specific versions (alleles) of the A1298C polymorphism were more common in individuals with OFCs compared to those without. They calculated odds ratios (ORs) and confidence intervals (CIs) to quantify the strength of any potential association.
- Additive Model (C vs. A): Each additional C allele increases risk.
- Homozygote Model (CC vs. AA): Compares individuals with two copies of the C allele to those with two copies of the A allele.
- Co-dominant Model (AC vs. AA): Examines the risk associated with having one A and one C allele compared to two A alleles.
- Dominant Model (CC + AC vs. AA): Combines individuals with either two C alleles or one A and one C allele and compares them to those with two A alleles.
- Recessive Model (CC vs. AC + AA): Compares individuals with two C alleles to everyone else.
An Evolving Evidence Base
Recent work continues to examine how genetic variation may contribute to orofacial clefts. Reviews suggest that the field is developing rather than settled, with researchers refining classifications, study designs, and statistical methods. MTHFR remains one research question within a broader investigation of cleft biology and risk.
Why One Gene Is Not Enough
The available evidence does not establish MTHFR as a single, definitive cause of cleft lip. Genetic associations can be difficult to reproduce across populations and study designs, particularly when the underlying condition has multiple contributing factors. Conclusions should therefore avoid treating an MTHFR variant as a diagnosis or as a guaranteed explanation for an individual case.
Maternal and Infant Variants
Studies have compared maternal and infant MTHFR C677T and A1298C variants in relation to nonsyndromic orofacial clefts. The evidence is conflicting: a meta-analysis of maternal variants reported no significant differences across allele, heterozygote, homozygote, dominant-model, or recessive-model comparisons, while another meta-analysis likewise reported no significant differences for infant variants across those genetic comparisons. One study specifically explored these variants in 261 Norwegian case-parent triads, illustrating how population and family-based designs add context without resolving the overall disagreement.
The Big Picture: Genetics, Environment, and OFC Risk
While this meta-analysis suggests that the MTHFR A1298C polymorphism alone is unlikely to be a primary driver of OFCs, it's important to remember that OFCs are complex conditions influenced by a multitude of factors. Other genes involved in folate metabolism, environmental exposures, and nutritional status during pregnancy can all play a role.
A Cautious Interpretation
Taken together, the question of whether MTHFR contributes to cleft lip risk remains one of association rather than certainty. Genetic findings must be considered alongside the broader biology of orofacial clefts and the limitations of individual studies. An MTHFR result should not be interpreted in isolation as a prediction of whether a cleft will occur.
Where Research Is Heading
Future work is expected to continue examining prevention of orofacial clefts and the management of affected patients. The Dentistry Journal's 2026 special issue aims to give international experts opportunities to publish studies on the current state of the art and perspectives for future research. This direction suggests continued emphasis on integrating new evidence into both prevention research and patient care.
Beyond a Single Variant
Orofacial clefts arise in a context more complex than any single genetic marker. Differences in research populations, access to specialist genetics services, and the availability of appropriate testing can affect how findings are interpreted and applied. Broader evaluation is therefore important when translating genetic research into clinical decisions.
Living With Cleft Conditions
Cleft conditions can affect daily life as well as medical care, and the consequences may extend across nutrition, speech, appearance, and ongoing treatment needs. Genetic findings may help researchers understand susceptibility, but they do not define a person's experience or outcome. Clear communication and individualized care remain important when discussing possible genetic contributions.
Prenatal folic acid supplementation has been shown to reduce the incidence of cleft lip in many populations. Maintaining adequate folate levels during pregnancy remains a crucial strategy for minimizing the risk of OFCs, particularly for women with other risk factors.
Future research should focus on exploring the interplay of multiple genetic variants and environmental factors to gain a more complete understanding of OFC etiology. Further investigation into gene-environment interactions will be critical for developing more effective prevention strategies and personalized risk assessments.